Relationship of hypoxia-inducible factor 1α and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Mizokami, Ken ^a   Kakeji, Yoshihiro ^a   Oda, Shinya ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER SIZE; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH;

EID: 33846001692     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-94     Document Type: Article

References (31)

1. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor I. Annu Rev Cell Dev Biol 1999, 15:551-578.
2. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000, 14:1983-1991.
3. Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM: Is the hypoxia-inducible factor pathway important in gastric cancer? Eur J Cancer 2005, 41:2792-2805.
4. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996, 379:88-91.
5. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzier KW, Vogelstein B: WAFI, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
6. Salnikow K, Costa M, Figg WD, Blagosklonny MV: Hyperinducibility of Hypoxia-responsive Genes without p53/p21-dependent Checkpoint in Aggressive Prostate Cancer. Cancer Res 2000, 60:5630-7113.
7. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E, Keshet E: Role of HIF-1 alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
8. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. Tokyo: Kanehara and Co, Ltd 1995, 12:1995.
9. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW: Overexpression of Hypoxia-inducible Factor 1 {{alpha}} in Common Human Cancers and Their Metastases. Cancer Res 1999, 59:5830-7113.
10. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K: Growth pattern and expressions of cell cycle regulator proteins p53 and p21WAF1/ CIP1 in early gastric carcinoma. Cancer 2001, 92:1828-1835.
11. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G: Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 2001, 7:1661-1668.
12. Kerr JF, Winterford CM, Harmon BV: Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994, 73:2013-2026.
13. Dixon WJ: BMDP statistical software. Berkeley, CA: University of California Press 1988.
14. Ogawa M, Maeda K, Onoda N, Chung YS, Sowa M: Loss of p21 WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 1997, 75:1617-1620.
15. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K: Increased proliferative activity caused by loss of p21(WAF1/CIP1) expression and its clinical significance in patients with early-stage gastric carcinoma. Cancer 2002, 94:2107-2112.
16. Birner P, Schindi M, Obermair A, Plank C, Breitenecker G, Oberhuber G: Overexpression of Hypoxia-inclucible Factor 1 {{alpha}} Is a Marker for an Unfavorable Prognosis in Early-Stage Invasive Cervical Cancer. Cancer Res 2000, 60:4693-7113.
17. Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rossler K, Prodinger A, Budka H, Hainfellner JA: Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 2001, 92:165-171.
18. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris AL: Hypoxia-inducible factors HIF-1 alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002, 62:2493-2497.
19. Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL: Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 2001, 158:1325-1334.
20. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL: HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001, 61:6669-6673.
21. Bruick RK: Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:9082-9087.
22. Iida T, Mine S, Fujimoto H, Suzuki K, Minami Y, Tanaka Y: Hypoxia-inducible factor-1 alpha induces cell cycle arrest of endothelial cells. Genes Cells 2002, 7:143-149.
23. Shimizu S, Eguchi Y, Kamiike W, Itoh Y, Hasegawa J, Yamabe K, Otsuki Y, Matsuda H, Tsujimoto Y: Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res 1996, 56:2161-2166.
24. Schmaltz C, Hardenbergh PH, Wells A, Fisher DE: Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 1998, 18:2845-2854.
25. Kinzler KW, Vogelstein B: Life (and death) in a malignant tumour. Nature 1996, 379:19-20.
26. Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr., Giaccia AJ: Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994, 14:6264-6277.
27. Suzuki H, Tomida A, Tsuruo T: Dephosphorylated hypoxia-inducible factor 1 alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 2001, 20:5779-5788.
28. Sumiyoshi Y, Kakeji Y, Egashira A, Mizokami K, Orita H, Maehara Y: Overexpression of hypoxia-inducible factor 1 alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 2006, 12:5112-5117.
29. Ratcliffe PJ, Pugh CW, Maxwell PH: Targeting tumors through the HIF system. Nat Med 2000, 6:1315-1316.
30. Dachs GLI, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ, Harris AL: Targeting gene expression to hypoxic tumor cells. Nat Med 1997, 3:515-520.
31. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nature Rev Cancer 2002, 2:38-47.